NCT05307354

Brief Summary

This randomized, clinical, single-blinded, controlledstudywasinitiallyplannedtoinclude 35 patients diagnosed with tarsal tunnel who applied to Kütahya Health Sciences University, Evliya Çelebi Training and Research Hospital, Physical Medicine and Rehabilitation outpatient clinic.Patients aged 20-55 years who were diagnosed with tarsal tunnel syndrome by electromyography (EMG) in the last 6 months were included in the study. The patients were randomized into two groups using the computer-assisted randomization method. Tibial nerve mobilization and foot-ankle range of motion exercises will be given to the study group, and only foot-ankle joint range of motion exercises will be given to the control group. All the patients were evaluated with the Visual Analog Scale (VAS), Foot Functional Index (FFI), Neuropathic Pain QuestionnaireN (NPQ) and Tibial Nerve ultrasonography before the intervention and at the fourth week of intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 1, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2022

Completed
Last Updated

July 20, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

March 24, 2022

Last Update Submit

July 19, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual analogue scale

    VAS, a scale consisting of a single line of 10 cm, was used to evaluate pain severity.

    Change from Baseline at 4th weeks

  • Evaluation of the tibial nerve with ultrasonography

    Bilateral tibial nerve US evaluation using a 6-18 Mhz linear probe (Mindray-UMT 200, USA) will be performed by another clinician experienced in musculoskeletal ultrasonography and blind to the clinical evaluation findings of patients.

    Change from Baseline at 4th weeks

  • Tinel's Sign

    It is performed by lightly tapping (percussing) over the nerve to elicit a sensation of tingling or "pins and needles" in the distribution of the Tibial nerve. The Tinel sign is the tingling or prickling sensation elicited by the percussion of an injured nerve trunk at or distal to the site of the lesion. The test is positive when a tingling or prickling sensation is felt in the distribution of the Tibial nerve.

    Change from Baseline at 4th weeks

Secondary Outcomes (2)

  • Foot Function Index

    Change from Baseline at 4th weeks

  • Neuropathic pain questionnaire

    Change from Baseline at 4th weeks

Study Arms (2)

Nerve Mobilization Group

EXPERIMENTAL

Tibial nerve mobilization in addition to foot-ankle joint range of motion exercises

Other: Tibial Nerve MobilizationOther: Foot-ankle range of motion exercises

Control group

ACTIVE COMPARATOR

Only joint range of motion exercises

Other: Foot-ankle range of motion exercises

Interventions

The person performing tibial nerve mobilization will start mobilization by keeping the lower extremity in a horizontal position, with the patient's hip and knee in 45° flexion and ankle in neutral position. Then, in order to mobilize the tibial nerve better, the patient will bring the patient's toes to the extension position, the ankle to the dorsiflexion and eversion position, and the knee joint to the extension to provide appropriate stabilization. Finally, while the patient is in this position, mobilization will be completed by plantar flexion of the distal ankle and flexion of the toes to allow the nerve to slide further distally. This mobilization technique will be performed by an experienced physician/physiotherapist twice a week for 4 weeks, and the patients will be given 5 sets of 10 cycles with a 1-minute rest period in each set.

Nerve Mobilization Group

In exercise program, foot-ankle joint range of motion exercises will be given. In our study, all exercises will be explained and performed once under the supervision of a physiotherapist, and then the participants will be asked to do all exercises with 10 repetitions, 3 times a day, for four weeks, without the supervision of a physiotherapist.

Control groupNerve Mobilization Group

Eligibility Criteria

Age20 Years - 55 Years
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients aged 20-55 years who were diagnosed with tarsal tunnel syndrome by electromyography (EMG) in the last 6 months were included in the study.

You may not qualify if:

  • Have a systemic inflammatory disease
  • Presence of a cognitive disorder, receiving psychotherapy or any psychiatric treatment, disease affecting the central nervous system
  • Being illiterate
  • Having hearing, vision problems
  • History of foot and ankle surgery
  • Any pathology that may cause pain in the foot joint diagnosed on physical examination
  • Inadequate function of any extremity that would prevent exercise
  • The presence of a balance disorder or a disease that can disrupt the balance
  • Diagnosis of advanced cardiac or lung disease for which exercise would be contraindicated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University

Kütahya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Nerve Compression SyndromesNeuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Merve Akdeniz LEBLEBİCİER, MD

    Kutahya Health Sciences University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2022

First Posted

April 1, 2022

Study Start

April 1, 2022

Primary Completion

June 15, 2022

Study Completion

July 6, 2022

Last Updated

July 20, 2022

Record last verified: 2022-03

Locations